The effect of cyclosporin A and FK 506 on the cAMP content in psoriatic keratinocytes

Skin Pharmacology and Physiology

Volumn 9, Issue 4, 1996, Pages 281-288

  Ockenfels, Hans Michael ^a   Nussbaum, Gregor ^a   Schneck, Birgit ^a   Wagner, Stephan N ^a   Haen, Ekkehard ^b   Goos, Manfred ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

cAMP; Keratinocytes; Psoriasis; Signal transduction

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; ISOPRENALINE; PROPRANOLOL; TACROLIMUS;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALE; PRIORITY JOURNAL; PSORIASIS; SIGNAL TRANSDUCTION;

ADULT; AGED; CYCLIC AMP; CYCLOSPORINE; FEMALE; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; PSORIASIS; SIGNAL TRANSDUCTION; TACROLIMUS;

EID: 0029775137     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000211426     Document Type: Article

References (37)

1. de Boer OJ, van der Loos CM, Ha-merlinck F, et al: Reappraisal of in situ immunophenotypic analysis of psoriasis skin. Arch Dermatol Res 1993;286:87-96.
2. Baker BS, Frey L: The immunology of psoriasis. Br J Dermatol 1992; 126:1-9.
3. Krüger JG, Krane JF, Carter DM, Gottlieb AB: Role of growth factors, cytokines and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 1990;94:135S-140S.
4. Kemeny L, Dobozy A, Ruzicka T: Cytokine system as a potential target for antipsoriatic therapy. Exp Dermatol 1994;3:1-8.
5. Prinz JC, Gross B, Vollmer S, Trommler P, Strobel I, Mcurer M, Plewig G: T cell clones from psoriasis skin lesions can promote kératinocyte proliferation in vitro via secreted products. Eur J Immunol 1994;24:593-598.
6. Yoshimura N, Oka T, Kita M: Combination therapy of cyclosporin with steroids inhibits gamma-interferon and interleukin-1 gene expression at the level of mRNA synthesis in vivo. J Clin Immunol 1989;9:322-328.
7. Liu J: FK 506 and CyA, molecular probes for studying intracellular signal transduction. Immunol Today 1993:14:290-295.
8. Powles AV, Baker BS, McFadden J. Griffiths CEM, Frey L, Valdimars-son H: Intralesional injection of cyclosporin in psoriasis. Lancet 1988: 1:537.
9. Furue M, Gaspari AA, Katz SI: The effect of CyA on epidermal cells. II. CyA inhibits proliferation of normal and transformed kératinocytes. J Invest Dermatol 1988;90:796-800.
10. Elder JT, Hammerberg C, Cooper KD, et al: Cyclosporin A rapidly inhibits epidermal cytokine expression in psoriasis lesions, but not in cytokine stimulated cultured kératinocytes. J Invest Dermatol 1993: 101:761-766.
11. Hayes JS, Brunton LL: Functional compartments in cyclic nucleotide action. J Cyclic Nucleotide Res 1982;8:1-16.
12. Voorhecs JJ, Duell ES: Psoriasis as a possible defect of the adenylcyclase-cyclic AMP cascade. Arch Dermatol 1971;104:354-358.
13. Voorhees JJ: Psoriasis as possible defect of adenylcyclasc cyclic AMP cascade. Arch Dermatol 1982,118: 863-868.
14. Abel EA, DiCicco LM, Orenberg EK. et al: Drugs in exacerbation of psoriasis. J Am Acad Dermatol 1986;15:1007-1022.
15. Gold MH, Holy AK, Roenigk HH: Beta-blocking drugs and psoriasis. J Am Acad Dermatol 1988; 19:837-841.
16. Schreiber G, Avissar S, et al: Lithium selective alteration of the function of brain versus cardiac Gs protein. Neuropharmacology 1990;29: 1067-1071.
17. Iwasaki T, Chen JD, Kim JP, Wynn KC, Woodley DT: Dibutyryl cyclic AMP modulates kcratinocyte migration without alteration of inte-grin expression. J Invest Dermatol 1994;102:891-897.
18. Boyce St, Ham RG: Normal human epidermal kératinocytes; in Weber MM, Sekely L (eds): In vitro Models for Cancer Research. Boca Raton. CRC Press, 1983, pp 245-274.
19. Bishop DK, Li W: Cyclosporin A and FK 506 mediate differential effects on T cell activation in vivo. J Immunol 1992;148:1049-1054.
20. Thomson AW, Nalesnik M, Abu-Elmagd K, et al: Influence of FK 506 on T lymphocytes, Langerhans cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions. Transplant Proc 1991;23:3330-3331.
21. Urabe MD, Kanitakis J, Thivolet J: CyA exerts a cytostatic effect in vivo on human and murine epithelial cells. Cancer 1990:66:936-940.
22. Mrowietz U: Vorstellungen zum Wirkmechanismus von Ciclosporin bei der Psoriasis. Hautarzt 1993;44: 353-360.
23. Ockenfels HM, Oeljeklaus P, Schneck B, Nussbaum G, Goos M: Cyclic AMP is markedly altered in T lymphocytes by psoriasis provoking and antipsoriatic drugs. J Invest Dermatol 1994:102:627.
24. Ockenfels HM, Wagner SN, Oeljc-klaus P, Schneck B, Nussbaum G, Jakobs KH, Goos M: Inhibition of T cell formation by CyA and FK506. Naunyn-Schmiedeberg’s Arch Pharmacol 1996,353:513-516.
25. Won Y-H, Sauder DN, McKenzie RC: Cyclosporin A inhibits kcratinocyte cytokine gene expression. Br J Dermatol 1994;130:312-319.
26. Nickoloff BJ, Fisher GJ, Mitra RS, Voorhees JJ: Direct cytopathic effect of CyA on rapidly proliferating cultured kératinocytes and fibroblasts. Transplant Proc 1988,20:85-90.
27. Cooper KD, Baadsgaard O, Duell E, et al: Langerhans cell sensitivity to in vitro versus in vivo loading with CyA. J Invest Dermatol 1992;98: 259-260.
28. Eedy DJ, Canavan JP, Shaw C, et al: Beta-adrenergic stimulation of cAMP is defective in cultured dermal fibroblasts of psoriatic subjects. Br J Dermatol 1990;122:477-483.
29. Beckner SK, Farrar WL: Interleukin 2 modulation of adenylate cyclase: Potential role of protein kinase C. J Biol Chem 1986,261:3043.
30. Raab WP: Cyclic nucleotides and prostaglandins in psoriasis, Int J Clin Pharmacol 1980; 18:212-224.
31. Derwahl M, Kuemmel M, et al: Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: Growth inhibition by cAMP. Biochcm Biophys Res Commun 1993;191:1131-1138.
32. Dumont JE, Jauniaux JC, Rogger PP: The cAMP-mediated stimulation of cell proliferation. Trends Biochem Sci 1989;14:67-71.
33. Webb DR, Stites DP, et al: Lymphocyte activation: The dualistic effect of cAMP. Biochem Biophys Res Commun 1973;53:1002.
34. Chakkalath HR, Jung LKL: Augmentation of phorbol ester-induced T cell proliferation by agents which raise intracellular cyclic adenosine monophosphate. Cell Immunol 1992;145:240-253.
35. Shcn M, McFadden G, Greenberg ME: Membrane depolarisation and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron 1990:4:571-572.
36. Lamph WW, Dwarki VJ, et al: Negative and positive regulation by transcription factor CREB protein is modulated by phosphorylation. Proc Natl Acad Sci USA 1990;87: 4320-4324.
37. Mirossay L, Chastre E, Empereur S, Gespach C: Cyclic AMP-responsive gene transcription in cellular proliferation and transformation. Int J Oncol 1992;1:1-13.